News & Insights

Markets
RNLX

Stock Alert: Renalytix Gains 17% On Winning Multi-year Contract

April 22, 2021 — 10:25 am EDT

Written by RTTNews.com for RTTNews ->

(RTTNews) - Renalytix AI plc (RNLX) shares are rising on Thursday morning trade as the company got a 10-year contract from the U.S. General Services Administration to provide KidneyIntelX early-stage kidney disease bio-prognostic testing services.

Currently, shares are at $29.64, up 17.53 percent from the previous close of $25.22 on average volume of 807,302. The shares have traded in a range of $9.91-$32.12 on average volume of 121,351 for the last 52 weeks.

The company noted that when the GSA contract will help KidneyIntelX testing to be available through the Federal Supply Schedule.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source ->

Stocks mentioned

RNLX

More Related Articles

Info icon

This data feed is not available at this time.

  • •

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.